Health Technology Assessment

Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets

  • Type:
    Extended Research Article Our publication formats
  • Authors:
    Richard Parnell,
    John Simes,
    Detailed Author information

    Borislava Mihaylova1,2,*, Runguo Wu2, Junwen Zhou1, Claire Williams1, Iryna Schlackow1, Jonathan Emberson3, Christina Reith3, Anthony Keech4, John Robson5, Richard Parnell6, Jane Armitage3, Alastair Gray1, John Simes4, Colin Baigent3

    • 1 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
    • 2 Health Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
    • 3 Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
    • 4 NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia
    • 5 Clinical Effectiveness Group, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
    • 6 Patient and public representative, Havant, UK
  • Funding:
    Health Technology Assessment programme
  • Journal:
  • Issue:
    Volume: 28, Issue: 79
  • Published:
  • Citation:
    Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, et al. Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets. Health Technol Assess 2024;28(79). https://doi.org/10.3310/KDAP7034
  • DOI:
Crossmark status check